Sphingolipid signaling pathways as potential therapeutic targets in gliomas

James R Van Brocklyn1

  • 1Department of Pathology, Division of Neuropathology, The Ohio State University, 4164 Graves Hall, 333 W. 10th Ave., Columbus, OH 43210, USA. james.vanbrocklyn@osumc.edu